There is no single best medicine for tremors because the right choice depends on what type of tremor you have, how severe it is, and what other health conditions are in play. That said, for the most common type, essential tremor, two medications stand out as first-line treatments: propranolol (a beta-blocker) and primidone (an anticonvulsant). Both have decades of evidence behind them and remain the starting point for most people.
The broader picture matters too. Tremors caused by Parkinson’s disease, dystonia, or other conditions respond to different treatments entirely. What works well for one tremor type can be useless for another.
Propranolol and Primidone for Essential Tremor
Essential tremor is the most common movement disorder, and propranolol and primidone are the two medications with the strongest track records for treating it. Head-to-head comparisons suggest primidone may have a slight edge. In one study published in Neurology, a single 250 mg dose of primidone reduced tremor amplitude by 60% within one to seven hours, and it outperformed propranolol in patients who had tried both.
Propranolol works by blocking the adrenaline signals that amplify tremor. It tends to be most helpful for tremors that appear when you hold a posture, like extending your hand, and it has also shown benefit for head tremor in essential tremor patients. Primidone works through a different mechanism, calming overactive nerve signaling in the brain. For people who can’t take beta-blockers due to asthma or other lung conditions, primidone is the preferred first choice.
Neither medication eliminates tremor completely. About 30% of people don’t respond adequately to either drug in the first year of treatment. Among those who do respond, roughly a third stop taking their medication during the second year because it stops working well enough or the side effects become too burdensome.
Side Effects That Shape the Decision
The “best” medicine often comes down to which side effects you can tolerate. Propranolol commonly causes fatigue, low blood pressure, and a slow heart rate. Over time, some people also experience depression or sexual dysfunction. It’s not an option if you have asthma, certain heart conditions, or very low blood pressure.
Primidone has a rougher start. Sedation, dizziness, and unsteadiness are common when you first begin taking it, and those early weeks can be genuinely difficult. The typical approach is to start at a very low dose, around 25 to 50 mg at bedtime, and increase slowly over four to six weeks. Many people who successfully get through this adjustment period report meaningful tremor improvement, but they describe having to push through several weeks of side effects before their body adapted. The maximum dose can go up to 750 mg per day, though few people tolerate that much because of persistent sedation and cognitive dulling.
These side effect profiles are why the choice between the two is personal. A younger, otherwise healthy person might do fine on propranolol. Someone with lung disease or low energy might prefer to try primidone despite its difficult startup period.
When First-Line Medications Don’t Work
If propranolol and primidone aren’t enough, topiramate is the most studied second-line option. In clinical trials involving over 200 participants, topiramate at an average dose of about 292 mg per day produced statistically significant improvements in tremor severity and functional disability compared to placebo. The catch: it has a high dropout rate. Cognitive side effects like difficulty finding words, along with drowsiness, drive many people to stop taking it.
Benzodiazepines like clonazepam and alprazolam can reduce tremor, but they carry real risks of sedation, dependence, and withdrawal symptoms, which limits their usefulness as long-term solutions. They’re sometimes used as add-on therapy for people with significant anxiety alongside their tremor, since anxiety reliably makes tremor worse.
Tremor Type Changes the Answer
The medications above apply mainly to essential tremor. Other tremor types call for different approaches.
Parkinson’s tremor, the classic resting tremor that occurs when your hand is relaxed in your lap, typically responds to dopamine-based medications that treat Parkinson’s disease more broadly. Propranolol can sometimes help with the postural component of Parkinson’s tremor, but it doesn’t address the underlying dopamine deficit.
Dystonic tremor, which occurs alongside involuntary muscle contractions that twist the body into abnormal postures, often responds well to botulinum toxin injections. In the limited controlled trials available, the effectiveness of these injections was particularly marked for dystonic tremor. The injections are targeted to specific muscles, which means fewer body-wide side effects than oral medications. Transient weakness in the injected muscles is the main downside, especially when wrist or finger muscles are involved. Despite strong results, only about 4% of eligible tremor patients currently receive this treatment.
Botulinum toxin is also an option for essential tremor when pills fail or cause intolerable side effects. Individualized injection protocols, where doctors target specific muscles based on each person’s tremor pattern, appear to produce the most consistent improvement.
Procedures for Medication-Resistant Tremor
When medications don’t provide adequate relief, two procedural options exist. Deep brain stimulation (DBS) involves implanting a small electrode in the brain that delivers continuous electrical pulses to interrupt tremor signals. Across studies with more than three years of follow-up, DBS produces a 31% to 88% improvement in tremor severity. A large meta-analysis of 439 patients found an average improvement of about 60% on objective tremor scales at 20 months.
Focused ultrasound is a newer, noninvasive alternative. It uses precisely aimed sound waves guided by MRI to create a tiny lesion in the brain area generating the tremor. The FDA has approved it for both essential tremor and tremor-dominant Parkinson’s disease when the tremor causes significant disability despite optimal medication. To qualify, you generally need to demonstrate that medications either aren’t controlling your tremor adequately or aren’t tolerated.
Both procedures target similar brain regions and can produce dramatic improvement, but they carry different risk profiles. DBS is reversible and adjustable but requires surgery and ongoing device management. Focused ultrasound is a one-time procedure with no implant but creates a permanent brain lesion that can’t be undone.
Matching Treatment to Your Situation
The practical reality is that tremor treatment is sequential. Most people start with propranolol or primidone, and the choice between them depends on your other health conditions and your tolerance for side effects. If the first medication doesn’t work well enough, switching to the other or adding topiramate is the usual next step. Botulinum toxin injections are a reasonable option at any stage, particularly if your tremor is localized to one area. Procedures like DBS and focused ultrasound are reserved for tremor that remains disabling after a fair trial of medications.
One important point: medications should be prescribed based on the type of tremor, not just its severity. A tremor that looks identical to essential tremor but is actually dystonic in origin will respond to completely different treatments. Getting the tremor type correctly diagnosed is the single most important step toward finding the medication that works best for you.